Epoch Biodesign Secures €10.3M to Revolutionize Plastic and Textile Waste Recycling with AI-Powered Enzymes
By Freecker • 2026-03-25T11:00:45.801776
In a significant breakthrough for sustainable technology, London-based BioTech startup Epoch Biodesign has raised €10.3 million to accelerate the commercialization of its innovative enzymatic recycling technology. This investment, which includes participation from notable partners such as Lululemon and KOMPAS VC, brings Epoch's total capital raised to over €43.1 million, underscoring the company's momentum in the race to solve the world's plastic and textile waste crisis.
Epoch Biodesign's technology combines artificial intelligence and advanced synthetic biology to design enzymes that can efficiently recycle end-of-life plastic and textile waste at a commercial scale. This ultra-low emission process produces virgin-quality recycled materials from mixed waste streams, offering a circular solution for industries reliant on nylon 6,6, such as apparel and automotive.
The significance of this development cannot be overstated. Nylon 6,6 is a crucial material for both the apparel and automotive industries, yet a circular solution has yet to be successful at scale. Epoch Biodesign's innovative approach uses AI to design enzymes capable of breaking down materials at the molecular level, allowing for the endless recycling of end-of-life and scrap materials that would otherwise be destined for landfills or incineration.
For everyday users, this could mean a significant reduction in the environmental impact of their clothing and automotive choices. As brands begin to integrate Epoch's recycled nylon 6,6 into their production lines, consumers can expect to see more sustainable products without compromising on quality. From an industry perspective, this shift could reshape how companies approach waste management and supply chain sustainability, potentially leading to a substantial decrease in the amount of waste sent to landfills.
The implications extend beyond the environmental benefits, as Epoch Biodesign's technology also offers a cost-effective solution for companies looking to reduce their reliance on virgin materials. With the ability to recycle blended textiles, multi-layer laminates, coated fibers, and various mixed automotive plastics, the potential applications of this technology are vast. As the company expands production from its pilot facility to a larger demonstration site, the fresh capital will be used to accelerate Epoch's global commercialization strategy and deepen partnerships in apparel, automotive, and beyond.
In conclusion, Epoch Biodesign's latest funding round marks a significant step forward in the fight against plastic and textile waste. With its innovative AI-powered enzymatic recycling technology, the company is poised to make a substantial impact on the sustainability of various industries, offering a beacon of hope for a more circular and environmentally conscious future.
Epoch Biodesign's technology combines artificial intelligence and advanced synthetic biology to design enzymes that can efficiently recycle end-of-life plastic and textile waste at a commercial scale. This ultra-low emission process produces virgin-quality recycled materials from mixed waste streams, offering a circular solution for industries reliant on nylon 6,6, such as apparel and automotive.
The significance of this development cannot be overstated. Nylon 6,6 is a crucial material for both the apparel and automotive industries, yet a circular solution has yet to be successful at scale. Epoch Biodesign's innovative approach uses AI to design enzymes capable of breaking down materials at the molecular level, allowing for the endless recycling of end-of-life and scrap materials that would otherwise be destined for landfills or incineration.
For everyday users, this could mean a significant reduction in the environmental impact of their clothing and automotive choices. As brands begin to integrate Epoch's recycled nylon 6,6 into their production lines, consumers can expect to see more sustainable products without compromising on quality. From an industry perspective, this shift could reshape how companies approach waste management and supply chain sustainability, potentially leading to a substantial decrease in the amount of waste sent to landfills.
The implications extend beyond the environmental benefits, as Epoch Biodesign's technology also offers a cost-effective solution for companies looking to reduce their reliance on virgin materials. With the ability to recycle blended textiles, multi-layer laminates, coated fibers, and various mixed automotive plastics, the potential applications of this technology are vast. As the company expands production from its pilot facility to a larger demonstration site, the fresh capital will be used to accelerate Epoch's global commercialization strategy and deepen partnerships in apparel, automotive, and beyond.
In conclusion, Epoch Biodesign's latest funding round marks a significant step forward in the fight against plastic and textile waste. With its innovative AI-powered enzymatic recycling technology, the company is poised to make a substantial impact on the sustainability of various industries, offering a beacon of hope for a more circular and environmentally conscious future.